According to a Research Report Published by Spherical Insights & Consulting, The United States Biochip Market Size is anticipated to Reach USD 18,006.0 Million by 2035, Growing at a CAGR of 11.12% from 2025 to 2035. The expansion of the United States biochip market is propelled by the expansion of next-generation sequencing (NGS) applications, the rise in drug research, and the expanding use of personalised medications.